MedTrace Logo

Personalized Antiplatelet Therapy in CAD Patients

NCT05174143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2021-12-30

No results posted yet for this study

Summary

This study is a prospective, no-randomized, single-center study performed on 15000 consecutive coronary artery patients from Dec. 2016 to Oct. 2021. All these patients were detected CYP2C19 genotype. The antiplatelet treatment was recorded according to the therapy actually adopted by the patients.

Conditions

Sponsors & Collaborators

  • Xinjiang Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2021-06-30
Completion
2021-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05174143 on ClinicalTrials.gov